Uncategorized

Embecta said its patch pump would require additions to be commercially competitive, and plans to use the funds saved to pay down debt.

It is not clear what specifically the new facility will produce, though Amgen could be ramping up its manufacturing capacity as it prepares to enter the obesity space with MariTide.

Protara is advancing a cell therapy that triggers both adaptive and innate antitumor immune responses, while CG Oncology’s approach makes use of an oncolytic immunotherapy that preferentially targets cancer cells and proliferates inside them, destroying them from the inside.

Eli Lilly is aggressively ramping up its manufacturing capacity for tirzepatide as compounding pharmacies continue to challenge an FDA decision to formally end the shortage of the obesity and diabetes drug.

  Plinko es un juego que ha ganado una popularidad indiscutible en las plataformas de casino en línea. Con su simplicidad y potencial para generar grandes premios, se ha convertido en un clásico que atrae tanto a jugadores novatos como a expertos. En este artículo, explo …

Not developing potency assays and gaining knowledge about MOAs early in the drug development process not only can break ATMP success but can cause costs and delays that lead to company closures.

Acutus has now tied two large layoffs to the Medtronic partnership. In November 2023, the firm cut about 160 people to focus on requirements of the manufacturing and distribution deal.

The insurer’s Anthem Blue Cross Blue Shield subsidiary is pulling the controversial policy, citing “significant widespread misinformation.”

U.S. approval of an expanded indication for transcatheter aortic valve replacement in patients without symptoms is among the growth catalysts Edwards outlined in an investor day presentation.

A jury found that competitor EOFlow and former executives misappropriated trade secrets for Insulet’s Omnipod insulin pumps.